MRNA

Moderna
MRNA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$10.26B
EV
$1.49B
Shares Outstanding
386.62M
Beta
2.23

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$49.96
P/E 2025E
-
P/Revenue 2025E
4.75x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Moderna, Inc.

gainify
MRNA

Moderna, Inc.

MRNA

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and ...

Sector

Healthcare

Industry

Biotechnology

CEO

Bancel, Stephane

Employees

5,800

IPO Date

2018-12-07

Headquarters

200 Technology Square, Cambridge, Massachusetts, 02139, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved